The Clinical Guide to Supportive and Palliative Care for HIV/AIDS

A Clinical Guide to Supportive and Palliative Care for HIV/AIDS • Drugs and Therapies Indexnelfinavir (Viracept)diarrhea cause, 563drug interactions, 573–577ketoconazole interaction, 554SCF penetration, 220neuroleptics, 112nevirapine (Viramune)drug interactions, 579–581hepatotoxicity, 562ketoconazole interaction, 554ritonavir interaction, 560SCF penetration, 220nitrofurantoin, 563Nizoral. see ketoconazoleNNRTIs (non-nucleoside reverse transcriptaseinhibitors)hepatotoxicity, 562rash cause, 563non-opioid analgesics, 104–106, 399Norpramin. see desipraminenortriptyline (Pamelor)pain management, 110sleep aid, 239Norvir. see ritonavirNSAIDs (nonsteroidal anti-inflammatory drugs)fever reduction, 130protease inhibitors interactions, 575renal toxicity, 106treatment guidelines, 104–106nystatin, 200Ooctreotide, 159olanzapine, 225, 228olanzapine (Clozaril), 560, 574omeprazole, 104, 567ondansetron, 163opiates, 571opioid analgesicsadministration in substance users, 262airway obstruction anxiety, 153alternative agents, 582and antidepressants, 112basic drug list, 399classes, 108constipation cause, 109diarrhea treatment, 159dyspnea relief, 148noncardiac chest pain, 151protease inhibitors interactions, 571, 575regulation, WHO guidelines, 400–401routes of administration, 108side effects, 109SSRI interaction, 559in terminal patients, 138–139treatment guidelines, 106–109Orap. see pimozideoromethazine, 163oxandrolone, 128oxycodonemild pain dosing, 105moderate pain dosing, 107PI interactions, 571oxygen therapy, 136–137, 148, 149PpaclitaxelKaposi’s sarcoma treatment, 197Pamelor. see nortriptylinepancreatic hormone, 159pancrelipase, 159paracetamol. see acetaminophenparegoricdiarrhea treatment, 158, 159paroxetine (Paxil)CYP450 inhibition, 558depression, 228pain management, 110, 111, 112panic/OCD, 228pemoline (Cylert)cognitive impairment, 221depression, 228fatigue, 125, 129pain management, 110, 113penicillin G, 189penicillin G-benzathine, 189penicillin V, 189penicillin VK (potassium), 168, 189pentamidinebone marrow suppression, 562drug interactions, 564nephrotoxicity, 562neuropsychiatric side effects, 223pancreatitis cause, 562pentobarbital, 141, 142, 154permethrin, 196perphenazine, 575phenobarbitalPI interactions, 574sedation dosing, 141, 142, 154phenothiazines, 110, 161, 163phenytoin, 110, 574pimozide (Orap), 110, 559piroxicam (Feldene), 560PIs. see protease inhibitorsprednisone, 124, 127primaquine, 564procabazine, 223prochlorperazine, 163promethazine, 163propoxyphene (Darvon), 105, 571protease inhibitorshepatotoxicity, 562ritonavir boost, 555–556SCF penetration, 220protease inhibitors (interactions), 571abused drugs, 571antidepressants, 559illicit drugs, 569–570opioid analgesics, 571statins, 568proton pump inhibitorsNNRTI interaction, 579NRTI interaction, 581vomiting relief, 162Prozac. see fluoxetinepsychostimulantsfatigue treatment, 124, 128–129neuropsychiatric disorders treatment, 220pain management, 110, 112–113600U.S. Department of Health and Human Services • Health Resources and Services Administration • HIV/AIDS Bureau